Physician
NY Arthritis PC
NY Arthritis PC was paid $2.69M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 96401, — 36% of everything it billed.
33Billing provider infoNY ARTHRITIS PC
BROOKLYN, NY 11229
BROOKLYN, NY 11229
33aNPI1346288255assigned 06/03/2006
33bProvider typeRheumatology Physician
28Total paid$2.69M
24GClaims67,753
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rheumatology Physician providers in New York
Rank by total paid#1 of 199
Median peer was paid$15K
This provider vs. median177×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,397 | $332K | |
| 2019 | 10,197 | $377K | |
| 2020 | 8,985 | $404K | |
| 2021 | 14,042 | $669K | |
| 2022 | 9,748 | $403K | |
| 2023 | 9,979 | $337K | |
| 2024incomplete | 6,405 | $172K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96401 | 36% | 14,436 | 4,893 | $974K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 7,522 | 6,309 | $554K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 16% | 8,063 | 3,537 | $418K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.6% | 2,424 | 2,258 | $232K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 7.9% | 1,641 | 1,566 | $214K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.5% | 648 | 645 | $95K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.6% | 543 | 210 | $44K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 3,065 | 1,356 | $41K |
| 99490 | Ccm add 20min | 1.1% | 835 | 821 | $29K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.0% | 384 | 379 | $28K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 168 | 89 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 301 | 123 | $8K |
41 more codes
| 20611 | <1% | 109 | $7K | |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 133 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 259 | $6K |
| 96415 | <1% | 215 | $6K | |
| 11901 | <1% | 50 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,982 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 995 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 144 | $1K |
| J9260 | Injection, methotrexate sodium, 50 mg | <1% | 1,134 | $978.92 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 58 | $936.64 |
| 83690 | <1% | 185 | $773.71 | |
| 80061 | Lipid panel | <1% | 118 | $693.96 |
| 81002 | <1% | 449 | $652.36 | |
| 83735 | <1% | 180 | $617.04 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 191 | $608.46 |
| 82150 | <1% | 172 | $570.73 | |
| 82550 | <1% | 142 | $552.59 | |
| 84100 | <1% | 168 | $520.38 | |
| 84550 | <1% | 143 | $483.36 | |
| 86140 | <1% | 138 | $461.64 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 433 | $420.28 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 426 | $401.22 |
| 86160 | <1% | 26 | $354.74 | |
| 86431 | <1% | 84 | $341.38 | |
| 86060 | <1% | 66 | $286.26 | |
| 85651 | <1% | 154 | $278.43 | |
| 1111F | <1% | 2,130 | $228.43 | |
| 1159F | <1% | 2,080 | $151.98 | |
| 1160F | <1% | 2,069 | $107.27 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 165 | $76.34 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 121 | $50.45 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 73 | $41.73 |
| J9250 | Methotrexate sodium, 5 mg | <1% | 8,616 | $25.15 |
| 76981 | <1% | 12 | $19.73 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $1.36 |
| J0135 | Injection, adalimumab, 20 mg | 0% | 748 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 479 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 13 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 137 | $0.00 |
| J0490 | Injection, belimumab, 10 mg | 0% | 881 | $0.00 |
| J1438 | Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKATZ, VICTORIA (OWNER)